Baird analyst Eric Coldwell raised the firm’s price target on Icon (ICLR) to $221 from $215 and keeps a Neutral rating on the shares. The firm ...
In a report released today, Jailendra Singh from Truist Financial maintained a Buy rating on Icon (ICLR – Research Report). The company’s ...
ICON's fourth-quarter 2024 earnings and revenues beat estimates as it manages to navigate a challenging transition period. Key Insights ICON's estimated fair value is US$345 based on 2 Stage Free ...
Clinical research conductor ICON Plc downplayed impacts from demand softness from the pharmaceutical and biotechnology ...
ICON Plc 's stock (NASDAQ:ICLR) has reached a 52-week low, dipping to $183.31, as the company navigates through a turbulent market environment. With a market capitalization of $15.19 billion and a P/E ...
For the full year 2024, ICON reported revenue of $8.28 billion, a 2% increase YoY. Adjusted diluted EPS rose 9.5% to $14.00. Looking ahead, the company reaffirmed its 2025 financial guidance, ...